• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙肝阳性肝细胞癌中lncRNA、微小RNA和mRNA表达改变的综合分析

Integrated Analysis of the Altered lncRNA, microRNA, and mRNA Expression in HBV-Positive Hepatocellular Carcinoma.

作者信息

Yu Jingya, Zhang Haibin, Zhang Yan, Zhang Xiaolu

机构信息

Department of Diagnostics, Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.

Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.

出版信息

Life (Basel). 2022 May 7;12(5):701. doi: 10.3390/life12050701.

DOI:10.3390/life12050701
PMID:35629368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9146868/
Abstract

Hepatitis B virus (HBV) infection is the most prominent risk factor for developing hepatocellular carcinoma (HCC), which can increase the incidence of HCC by more than 100 times. Accumulated evidence has revealed that non-coding RNAs (ncRNAs) play a regulatory role in various tumors through the long non-coding RNA (lncRNA)-microRNA (miRNA)-mRNA regulation axis. However, the involvement of the ncRNA regulatory network in the progression of HBV infection-induced HCC remains elusive. In the current work, five tumor samples from patients with hepatitis B surface antigen (HBsAg)-positive HCC and three tumor samples from patients with HBsAg-negative HCC were collected for whole-transcriptome sequencing. Between the two groups, 841 lncRNAs, 54 miRNAs, and 1118 mRNAs were identified to be differentially expressed (DE). The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses indicated that DE genes were mainly involved in cancer-related pathways, including Wnt and MAPK signaling pathways. The Gene Expression Omnibus (GEO) analysis further validated the selected DE mRNAs. The DE lncRNA-miRNA-mRNA network was built to explore the effect of HBV infection on the regulation of ncRNAs in HCC. These findings provide novel insights into the role of HBV infection in the progression of HCC.

摘要

乙型肝炎病毒(HBV)感染是发生肝细胞癌(HCC)最主要的危险因素,可使HCC的发病率增加100多倍。越来越多的证据表明,非编码RNA(ncRNA)通过长链非编码RNA(lncRNA)-微小RNA(miRNA)-信使核糖核酸(mRNA)调控轴在各种肿瘤中发挥调节作用。然而,ncRNA调控网络在HBV感染诱导的HCC进展中的作用仍不清楚。在当前研究中,收集了5例乙型肝炎表面抗原(HBsAg)阳性HCC患者的肿瘤样本和3例HBsAg阴性HCC患者的肿瘤样本进行全转录组测序。在两组之间,共鉴定出841种lncRNA、54种miRNA和1118种mRNA存在差异表达(DE)。基因本体论(GO)和京都基因与基因组百科全书(KEGG)分析表明,差异表达基因主要参与癌症相关途径,包括Wnt和丝裂原活化蛋白激酶(MAPK)信号通路。基因表达综合数据库(GEO)分析进一步验证了所选的差异表达mRNA。构建差异表达lncRNA-miRNA-mRNA网络以探讨HBV感染对HCC中ncRNA调控的影响。这些发现为HBV感染在HCC进展中的作用提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad88/9146868/5e1e24c8db34/life-12-00701-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad88/9146868/9484df943135/life-12-00701-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad88/9146868/bf5e6bf55453/life-12-00701-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad88/9146868/d10152b71f62/life-12-00701-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad88/9146868/fdc2025a00ed/life-12-00701-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad88/9146868/42ba7e2eb964/life-12-00701-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad88/9146868/a5301a7e4c76/life-12-00701-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad88/9146868/5e1e24c8db34/life-12-00701-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad88/9146868/9484df943135/life-12-00701-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad88/9146868/bf5e6bf55453/life-12-00701-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad88/9146868/d10152b71f62/life-12-00701-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad88/9146868/fdc2025a00ed/life-12-00701-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad88/9146868/42ba7e2eb964/life-12-00701-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad88/9146868/a5301a7e4c76/life-12-00701-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad88/9146868/5e1e24c8db34/life-12-00701-g007.jpg

相似文献

1
Integrated Analysis of the Altered lncRNA, microRNA, and mRNA Expression in HBV-Positive Hepatocellular Carcinoma.乙肝阳性肝细胞癌中lncRNA、微小RNA和mRNA表达改变的综合分析
Life (Basel). 2022 May 7;12(5):701. doi: 10.3390/life12050701.
2
Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.鉴定参与 HBV 相关 HCC 发病机制的潜在 miRNA-mRNA 调控网络。
J Transl Med. 2019 Jan 3;17(1):7. doi: 10.1186/s12967-018-1761-7.
3
Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌患者中长链非编码RNA表达谱的改变
J Huazhong Univ Sci Technolog Med Sci. 2013 Feb;33(1):96-101. doi: 10.1007/s11596-013-1078-y. Epub 2013 Feb 8.
4
Comprehensive Analysis of circRNA, lncRNA, miRNA and mRNA Expression Profiles and Their Competing Endogenous RNA Networks in Hepatitis B Virus-Related Hepatocellular Carcinoma.乙型肝炎病毒相关肝细胞癌中环状RNA、长链非编码RNA、微小RNA和信使RNA表达谱及其竞争性内源RNA网络的综合分析
Mol Biotechnol. 2025 Jan;67(1):329-341. doi: 10.1007/s12033-024-01056-2. Epub 2024 Feb 27.
5
Identification Of Novel lncRNAs For Detection Of HBV-Associated Hepatocellular Carcinoma.用于检测乙肝相关肝细胞癌的新型长链非编码RNA的鉴定
Onco Targets Ther. 2019 Nov 27;12:10199-10211. doi: 10.2147/OTT.S230377. eCollection 2019.
6
Integrated Analysis of Altered lncRNA, circRNA, microRNA, and mRNA Expression in Hepatocellular Carcinoma Carrying TERT Promoter Mutations.携带端粒酶逆转录酶(TERT)启动子突变的肝细胞癌中lncRNA、circRNA、microRNA和mRNA表达改变的综合分析
J Hepatocell Carcinoma. 2022 Nov 29;9:1201-1215. doi: 10.2147/JHC.S385026. eCollection 2022.
7
Non-coding RNA Identification in Osteonecrosis of the Femoral Head Using Competitive Endogenous RNA Network Analysis.使用竞争性内源性RNA网络分析鉴定股骨头坏死中的非编码RNA
Orthop Surg. 2021 May;13(3):1067-1076. doi: 10.1111/os.12834. Epub 2021 Mar 21.
8
MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.HBV 诱导感染和肝细胞癌中的 microRNA 谱。
BMC Cancer. 2017 Dec 1;17(1):805. doi: 10.1186/s12885-017-3816-1.
9
Aberrant expression of two miRNAs promotes proliferation, hepatitis B virus amplification, migration and invasion of hepatocellular carcinoma cells: evidence from bioinformatic analysis and experimental validation.两种微小RNA的异常表达促进肝癌细胞的增殖、乙型肝炎病毒扩增、迁移和侵袭:来自生物信息学分析和实验验证的证据
PeerJ. 2020 Apr 29;8:e9100. doi: 10.7717/peerj.9100. eCollection 2020.
10
Construction and Comprehensive Analyses of a Competing Endogenous RNA Network in Tumor-Node-Metastasis Stage I Hepatocellular Carcinoma.构建并综合分析肿瘤-淋巴结-转移(TNM)Ⅰ期肝癌中的竞争内源性 RNA 网络。
Biomed Res Int. 2020 Feb 11;2020:5831064. doi: 10.1155/2020/5831064. eCollection 2020.

引用本文的文献

1
Plant long noncoding RNAs: why do we not know more?植物长链非编码RNA:为何我们了解得还不够多?
Biol Res. 2025 Jun 10;58(1):37. doi: 10.1186/s40659-025-00610-9.
2
Diagnosis of hepatocellular carcinoma using liquid biopsy-based biomarkers: a systematic review and network meta-analysis.基于液体活检生物标志物诊断肝细胞癌:系统评价与网状Meta分析
Front Oncol. 2025 Jan 28;14:1483521. doi: 10.3389/fonc.2024.1483521. eCollection 2024.
3
FN1, a reliable prognostic biomarker for thyroid cancer, is associated with tumor immunity and an unfavorable prognosis.

本文引用的文献

1
miR-143-5p suppresses breast cancer progression by targeting the HIF-1α-related GLUT1 pathway.微小RNA-143-5p通过靶向缺氧诱导因子-1α相关的葡萄糖转运蛋白1途径抑制乳腺癌进展。
Oncol Lett. 2022 May;23(5):147. doi: 10.3892/ol.2022.13268. Epub 2022 Mar 15.
2
LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing NDRG1 promoter activity.LINC01419 通过增强 NDRG1 启动子活性促进肝癌细胞增殖和转移。
Cell Oncol (Dordr). 2020 Oct;43(5):931-947. doi: 10.1007/s13402-020-00540-6. Epub 2020 Jun 15.
3
HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1α.
纤连蛋白1(FN1)是甲状腺癌可靠的预后生物标志物,与肿瘤免疫及不良预后相关。
Oncol Lett. 2024 Aug 26;28(5):510. doi: 10.3892/ol.2024.14643. eCollection 2024 Nov.
4
Endocrine and cellular physiology and pathology of the insulin-like growth factor acid-labile subunit.胰岛素样生长因子酸不稳定亚基的内分泌和细胞生理学及病理学。
Nat Rev Endocrinol. 2024 Jul;20(7):414-425. doi: 10.1038/s41574-024-00970-4. Epub 2024 Mar 21.
5
miRNA and lncRNA as potential tissue biomarkers in hepatocellular carcinoma.微小RNA和长链非编码RNA作为肝细胞癌潜在的组织生物标志物
Noncoding RNA Res. 2023 Oct 24;9(1):24-32. doi: 10.1016/j.ncrna.2023.10.010. eCollection 2024 Mar.
6
Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers.感染因子导致原发性肝癌中Wnt/β-连环蛋白信号通路失调。
Microorganisms. 2023 Jun 22;11(7):1632. doi: 10.3390/microorganisms11071632.
HIPK2 通过促进 HIF-1α 的降解来抑制肝癌的生长和进展。
Oncogene. 2020 Apr;39(14):2863-2876. doi: 10.1038/s41388-020-1190-y. Epub 2020 Feb 7.
4
miR-210-5p promotes epithelial-mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells.miR-210-5p 通过抑制 PIK3R5 促进上皮-间充质转化,从而激活骨肉瘤细胞的致癌自噬。
Cell Death Dis. 2020 Feb 5;11(2):93. doi: 10.1038/s41419-020-2270-1.
5
LncRNA NEAT1 Promotes Proliferation, Migration And Invasion Via Regulating miR-296-5p/CNN2 Axis In Hepatocellular Carcinoma Cells.长链非编码RNA NEAT1通过调控miR-296-5p/CNN2轴促进肝癌细胞的增殖、迁移和侵袭。
Onco Targets Ther. 2019 Nov 18;12:9887-9897. doi: 10.2147/OTT.S228917. eCollection 2019.
6
The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis.MicroRNA 在乙型肝炎病毒相关性肝细胞癌(HBV-HCC)发病机制中的调控作用。
Cells. 2019 Nov 24;8(12):1504. doi: 10.3390/cells8121504.
7
Long non‑coding RNAs in HBV‑related hepatocellular carcinoma (Review).长链非编码 RNA 在乙型肝炎病毒相关性肝细胞癌中的作用(综述)。
Int J Oncol. 2020 Jan;56(1):18-32. doi: 10.3892/ijo.2019.4909. Epub 2019 Nov 12.
8
Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth.外泌体 miR-21 通过调控 TETs/PTENp1/PTEN 通路促进肝癌生长。
Mol Cancer. 2019 Oct 27;18(1):148. doi: 10.1186/s12943-019-1075-2.
9
Hepatocellular Carcinoma.肝细胞癌
N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.
10
The lncRNA ZEB2-AS1 is upregulated in gastric cancer and affects cell proliferation and invasion via miR-143-5p/HIF-1α axis.长链非编码RNA ZEB2-AS1在胃癌中上调,并通过miR-143-5p/HIF-1α轴影响细胞增殖和侵袭。
Onco Targets Ther. 2019 Jan 18;12:657-667. doi: 10.2147/OTT.S175521. eCollection 2019.